Home › NDC Lookup › RxCUI directory › RxCUI 2699342

2.25 ML paliperidone palmitate 156 MG/ML Prefilled Syringe — RxCUI 2699342

RxNorm drug concept · Semantic clinical drug
RxCUI 2699342 Semantic clinical drug · SCD ● Current RxNorm concept 6 FDA products 7 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2699342
Official name2.25 ML paliperidone palmitate 156 MG/ML Prefilled Syringe
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aspaliperidone palmitate 351 MG per 2.25 ML Prefilled Syringe; paliperidone palmitate 351 MG in 2.25 ML Prefilled Syringe; paliperidone palmitate 351 MG per 2.25 ML Extended Release Injectable Suspension in a Prefilled Syringe
FDA products mapped6
Package NDCs mapped7
Reported Medicaid activity (SDUD)261 prescriptions · 4 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Paliperidone: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Paliperidone is an antipsychotic medication used to treat schizophrenia and schizoaffective disorder. It works by calming overactive signals in the brain — specifically blocking ce...
  • What exactly does paliperidone do — why did my doctor prescribe it?
  • Yes — swallow the tablet whole. Don't chew it, crush it, or split it. The tablet is specially designed to release the medication slowly over the day, and breaking it would release...
  • I've been prescribed the tablet form. Is there anything special about how I take it?
📖 Read our full Paliperidone guide →

🕸️ Concept Web — How 2.25 ML paliperidone palmitate 156 MG/ML Prefill... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 2.25 ML paliperidone palmitate 156 MG/ML Prefilled Syringe RxCUI 2699342

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Paliperidone 679314
    • Paliperidone palmitate 858045
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Erzofri 2699343
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Paliperidone Prefilled Syringe 858047
    • Paliperidone palmitate Prefilled Syringe 2647004
    • Paliperidone Injectable Product 1160708
    • Paliperidone palmitate Injectable Product 2659828
    • Paliperidone Prefilled Syringe [Erzofri] 2699346
    • Paliperidone palmitate Prefilled Syringe [Erzofri] 2699347
    • Erzofri Injectable Product 2699345
    • Prefilled Syringe 721656
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Paliperidone palmitate 156 MG/ML SCDC · 858046
  • Paliperidone Prefilled Syringe SCDF · 858047
  • Paliperidone palmitate Prefilled Syringe SCDFP · 2647004
  • Paliperidone Injectable Product SCDG · 1160708
  • Paliperidone palmitate Injectable Product SCDGP · 2659828

Brand-Name Concepts

📦 FDA Products & Package NDCs

6 products · 7 package NDCs
7 package NDCs map to RxCUI 2699342 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
72526-0105-11 1 SYRINGE, GLASS in 1 KIT (72526-105-11) / .25 mL in 1 SYRI... Erzofri extended-release Shandong Luye Pharmaceutical Co., Ltd. 2024-12-10
72526-0106-11 1 SYRINGE, GLASS in 1 KIT (72526-106-11) / .5 mL in 1 SYRIN... Erzofri extended-release Shandong Luye Pharmaceutical Co., Ltd. 2024-12-10
72526-0107-11 1 SYRINGE, GLASS in 1 KIT (72526-107-11) / .75 mL in 1 SYRI... Erzofri extended-release Shandong Luye Pharmaceutical Co., Ltd. 2024-12-10
72526-0108-11 1 SYRINGE, GLASS in 1 KIT (72526-108-11) / 1 mL in 1 SYRING... Erzofri extended-release Shandong Luye Pharmaceutical Co., Ltd. 2024-12-10
72526-0109-11 1 SYRINGE, GLASS in 1 KIT (72526-109-11) / 1.5 mL in 1 SYRI... Erzofri extended-release Shandong Luye Pharmaceutical Co., Ltd. 2024-12-10
72526-0110-11 1 SYRINGE, GLASS in 1 KIT (72526-110-11) / 2.25 mL in 1 SYR... Erzofri extended-release Shandong Luye Pharmaceutical Co., Ltd. 2024-12-10
72526-0110-21 1 SYRINGE, GLASS in 1 KIT (72526-110-21) / 2.25 mL in 1 SYR... Erzofri extended-release Shandong Luye Pharmaceutical Co., Ltd. 2025-03-20
Observed labelers: Shandong Luye Pharmaceutical Co., Ltd. (7) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J2428 Inj, erzofri, 1 mg 6 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.